有毒 发表于 2025-3-25 04:02:30

Submitted on: 16 December 2024.
Revised on: 10 April 2025.
Accepted on: 02 June 2025.

___________________Clinical Advances in Hematology & Oncology

A简洁的 发表于 2025-3-25 07:43:32

Submitted on: 28 February 2000.
Revised on: 17 April 2000.
Accepted on: 17 May 2000.

___________________Clinical Advances in Hematology & Oncology

存在主义 发表于 2025-3-25 12:48:29

Submitted on: 27 November 2001.
Revised on: 17 January 2002.
Accepted on: 12 February 2002.

___________________Clinical Advances in Hematology & Oncology

prostate-gland 发表于 2025-3-25 18:36:29

Submitted on: 16 April 2000.
Revised on: 21 May 2000.
Accepted on: 14 July 2000.

___________________Clinical Advances in Hematology & Oncology

Mnemonics 发表于 2025-3-25 20:16:43

http://reply.papertrans.cn/1/56/5545/5545-25.png

鄙视 发表于 2025-3-26 01:50:19

http://reply.papertrans.cn/1/56/5545/5545-26.png

阐释 发表于 2025-3-26 08:04:35

Submitted on: 21 December 2005.
Revised on: 12 February 2006.
Accepted on: 08 April 2006.

___________________Clinical Advances in Hematology & Oncology

EXALT 发表于 2025-3-26 11:28:03

http://reply.papertrans.cn/1/56/5545/5545-28.png

Console 发表于 2025-3-26 13:15:42

http://reply.papertrans.cn/1/56/5545/5545-29.png

同位素 发表于 2025-3-26 20:51:33

http://reply.papertrans.cn/1/56/5545/5545-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Clinical Advances in Hematology & Oncology 2024/2025影响因子:1.154 (CLIN ADV HEMATOL ONC) (1543-0790). (ONCOLOGY)(肿瘤学